Rigel Pharmaceuticals' IPO

Rigel Pharmaceuticals raised a round of funding on July 07, 2003. Investors include Public.

Rigel Pharmaceuticals discovers and develops drugs for the treatment of inflammatory/ autoimmune diseases and cancer, as well as viral and metabolic diseases. Their research focuses on intracellular s…

Articles about Rigel Pharmaceuticals' IPO: